Pfizer and Amgen Among 22 Firms Expanding in Hong Kong
Pfizer (PFE) and Amgen (AMGN), both valued at over HK$1T, are among 22 firms planning to expand or open offices in Hong Kong, according to the South China Morning Post. The move highlights continued interest in Hong Kong as a strategic business hub despite ongoing geopolitical and economic challenges.
Topics: Amgen Biotech Corporate Strategy Hong Kong Expansion Pfizer